India can become future leader in biomedical innovation: Bayer CEO
Bayer CEO Bill Anderson sees India as a future leader in biomedical innovation, saying the country has the brainpower to shape the industry if it boosts protections for new ideas and data.
He shared these thoughts during his first visit to India.
Anderson calls India a great place for investment
Anderson called India a great place for investment, highlighting its young, tech-savvy population and potential for growth.
He also noted that helping 150 million farmers shift to better farming methods and biofuels could be a game-changer.
Bayer already has big operations here in crop science, pharmaceuticals, and consumer health.
Bayer is opening an AI center in Bengaluru
Bayer is opening an AI center in Bengaluru to work on advanced tech projects with Indian talent.
The company also highlighted that direct-seeded rice can reduce water use and methane emissions by roughly 40-50%.
India could learn from China and Brazil, says Anderson
Anderson suggested India could learn from China and Brazil by separating public health services from those aimed at the middle class.
He pointed out that giving biotech companies more years of exclusivity helped boost innovation in China.